Bayer and Iambic collaborate to advance drug discovery with AI
Iambic official newsroom · 行业原文收录 · 来源发布：Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:35 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Bayer and Iambic collaborate to advance drug discovery with AI Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research and development portfolio by harnessing AI to accelerate drug discovery Berlin, Germany and San Diego, USA, June 22, 2026 – Bayer and Iambic Therapeutics Inc., a clinica
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。